Zamzami N, Marzo I, Susin S A, Brenner C, Larochette N, Marchetti P, Reed J, Kofler R, Kroemer G
Centre National de la Recherche Scientifique, Unité Propre de Recherche 420, Villejuif, France.
Oncogene. 1998 Feb 26;16(8):1055-63. doi: 10.1038/sj.onc.1201864.
In several different cell lines, Bcl-2 prevents the induction of apoptosis (DNA fragmentation, PARP cleavage, phosphatidylserine exposure) by the pro-oxidant ter-butylhydroperoxide (t-BHP) but has no cytoprotective effect when apoptosis is induced by the thiol crosslinking agent diazenedicarboxylic acid his 5N,N-dimethylamide (diamide). Both t-BHP and diamide cause a disruption of the mitochondrial transmembrane potential delta psi(m) that is not inhibited by the broad spectrum caspase inhibitor z-VAD.fmk, although z-VAD.fmk does prevent nuclear DNA fragmentation and poly(ADP-ribose) polymerase cleavage in these models. Bcl-2 stabilizes the delta psi(m) of t-BHP-treated cells but has no inhibitory effect on the delta psi(m) collapse induced by diamide. As compared to normal controls, isolated mitochondria from Bcl-2 overexpressing cells are relatively resistant to the induction of delta psi(m) disruption by t-BHP in vitro. Such Bcl-2 overexpressing mitochondria also fail to release apoptosis-inducing factor (AIF) and cytochrome c from the intermembrane space, whereas control mitochondria not overexpressing Bcl-2 do liberate AIF and cytochrome c in response to t-BHP. In contrast, Bcl-2 does not confer protection against diamide-triggered delta psi(m) collapse and the release of AIF and cytochrome c. This indicates that Bcl-2 suppresses the permeability transition (PT) and the associated release of intermembrane proteins induced by t-BHP but not by diamide. To further investigate the mode of action of Bcl-2, semi-purified PT pore complexes were reconstituted in liposomes in a cell-free, organelle-free system. Recombinant Bcl-2 or Bcl-X(L) proteins augment the resistance of reconstituted PT pore complexes to pore opening induced by t-BHP. In contrast, mutated Bcl-2 proteins which have lost their cytoprotective potential also lose their PT-modulatory capacity. Again, Bcl-2 fails to confer protection against diamide in this experimental system. The reconstituted PT pore complex itself cannot release cytochrome c encapsulated into liposomes. Altogether these data suggest that pro-oxidants, thiol-reactive agents, and Bcl-2 can regulate the PT pore complex in a direct fashion, independently from their effects on cytochrome c. Furthermore, our results suggest a strategy for inducing apoptosis in cells overexpressing apoptosis-inhibitory Bcl-2 analogs.
在几种不同的细胞系中,Bcl-2可防止促氧化剂叔丁基过氧化氢(t-BHP)诱导细胞凋亡(DNA片段化、PARP裂解、磷脂酰丝氨酸暴露),但当凋亡由硫醇交联剂二氮杂环庚二酸双(5-N,N-二甲基酰胺)(二酰胺)诱导时,Bcl-2没有细胞保护作用。t-BHP和二酰胺都会导致线粒体跨膜电位Δψ(m)的破坏,这种破坏不受广谱半胱天冬酶抑制剂z-VAD.fmk的抑制,尽管在这些模型中z-VAD.fmk确实能防止核DNA片段化和聚(ADP-核糖)聚合酶裂解。Bcl-2可稳定t-BHP处理细胞的Δψ(m),但对二酰胺诱导的Δψ(m)崩溃没有抑制作用。与正常对照相比,来自过表达Bcl-2的细胞的分离线粒体在体外对t-BHP诱导的Δψ(m)破坏相对具有抗性。这种过表达Bcl-2的线粒体也不能从膜间隙释放凋亡诱导因子(AIF)和细胞色素c,而未过表达Bcl-2的对照线粒体在t-BHP作用下会释放AIF和细胞色素c。相反,Bcl-2不能保护细胞免受二酰胺触发的Δψ(m)崩溃以及AIF和细胞色素c的释放。这表明Bcl-2可抑制t-BHP诱导的通透性转换(PT)及相关膜间隙蛋白的释放,但不能抑制二酰胺诱导的这些过程。为了进一步研究Bcl-2的作用方式,在无细胞、无细胞器的系统中,将半纯化的PT孔复合物重组到脂质体中。重组的Bcl-2或Bcl-X(L)蛋白增强了重组PT孔复合物对t-BHP诱导的孔开放的抗性。相反,已失去细胞保护潜能的突变Bcl-2蛋白也失去了其PT调节能力。同样,在这个实验系统中Bcl-2不能保护细胞免受二酰胺的影响。重组的PT孔复合物本身不能释放包裹在脂质体中的细胞色素c。总之,这些数据表明促氧化剂、硫醇反应性试剂和Bcl-2可以直接调节PT孔复合物,这与其对细胞色素c的作用无关。此外,我们的结果提示了一种在过表达凋亡抑制性Bcl-2类似物的细胞中诱导凋亡的策略。